Search results
Results from the WOW.Com Content Network
Levacetylleucine, sold under the brand name Aqneursa, is a medication used for the treatment of neurological manifestations of Niemann-Pick disease type C. [1] [2] Levacetylleucine is a modified version of the amino acid leucine (N-Acetyl-L-Leucine). [1]
Hydromorphone 2 mg IV is equivalent to approximately 10 mg morphine IV. [9] Hydromorphone was patented in 1923. [12] Hydromorphone is made from morphine. [13] It is on the World Health Organization's List of Essential Medicines. [14] It is available as a generic medication. [7]
Trihexyphenidyl (THP, benzhexol, trihex, marketed as Artane and others) is an antispasmodic drug used to treat stiffness, tremors, spasms, and poor muscle control. It is an agent of the antimuscarinic class and is often used in management of Parkinson's disease.
Phenelzine 15 mg tablets. Phenelzine is administered orally in the form of phenelzine sulfate [4] and is rapidly absorbed from the gastrointestinal tract. [33] The time to peak plasma concentration is 43 minutes, and the half-life is 11.6 hours. [34] Unlike most other drugs, phenelzine irreversibly disables MAO.
Racepinefrine (INN Tooltip International Nonproprietary Name, USAN Tooltip United States Adopted Name), or racepinephrine, sold under the brand name Vaponefrin among others, is a sympathomimetic medication described as a vasoconstrictor, bronchodilator, cardiostimulant, mydriatic, and antiglaucoma agent.
Nitazoxanide alone has shown preliminary evidence of efficacy in the treatment of chronic hepatitis B over a one-year course of therapy. [17] Nitazoxanide 500 mg twice daily resulted in a decrease in serum HBV DNA in all of 4 HBeAg-positive patients, with undetectable HBV DNA in 2 of 4 patients, loss of HBeAg in 3 patients, and loss of HBsAg in one patient.
Tolvaptan, sold under the brand name Samsca among others, is an aquaretic drug that functions as a selective, competitive vasopressin receptor 2 (V 2) antagonist used to treat hyponatremia (low blood sodium levels) associated with congestive heart failure, cirrhosis, and the syndrome of inappropriate antidiuretic hormone (SIADH).
Suvorexant is used for the treatment of insomnia, characterized by difficulties with sleep onset and/or sleep maintenance, in adults. [2] [6] At a dose of 15 to 20 mg and in terms of treatment–placebo difference, it reduces time to sleep onset by up to 10 minutes, reduces time awake after sleep onset by about 15 to 30 minutes, and increases total sleep time by about 10 to 20 minutes. [2]